OC Spine, a division of OC Medical Devices, announced the first clinical cases of their Focus Interbody system featuring the xCELLerate bioactive coating.
The hydrophilic nature of xCELLerate has been shown to attract and absorb blood, increasing the growth factors needed to promote the integration of bone to the implant. The system received FDA marketing clearance in late 2022.
Jason Bazemore, Vice President of Sales & Marketing shared “We are thrilled to work with such a skilled clinician as Dr. Peterson and grateful to the staff and administration at The Hospital at Westlake for helping facilitate this launch. As a startup company, feedback from surgeons like Dr. Peterson is how we can react quickly to make changes to our systems before making the substantial investment needed for a full commercial launch. Our xCELLerate bioactive coating is a game changer for us, and we will incorporate it on future product offerings in our development pipeline.”
OC Spine, a division of OC Medical Devices, announced the first clinical cases of their Focus Interbody system featuring the xCELLerate bioactive coating.
The hydrophilic nature of xCELLerate has been shown to attract and absorb blood, increasing the growth factors needed to promote the integration of bone to the implant. The system received...
OC Spine, a division of OC Medical Devices, announced the first clinical cases of their Focus Interbody system featuring the xCELLerate bioactive coating.
The hydrophilic nature of xCELLerate has been shown to attract and absorb blood, increasing the growth factors needed to promote the integration of bone to the implant. The system received FDA marketing clearance in late 2022.
Jason Bazemore, Vice President of Sales & Marketing shared “We are thrilled to work with such a skilled clinician as Dr. Peterson and grateful to the staff and administration at The Hospital at Westlake for helping facilitate this launch. As a startup company, feedback from surgeons like Dr. Peterson is how we can react quickly to make changes to our systems before making the substantial investment needed for a full commercial launch. Our xCELLerate bioactive coating is a game changer for us, and we will incorporate it on future product offerings in our development pipeline.”
Copy to clipboard 
